1. Cost-effectiveness of
- Author
-
Sandrine, Loubière, Alexandre, Drezet, Michèle, Beau-Faller, Denis, Moro-Sibilot, Sylvie, Friard, Marie, Wislez, Hélène, Blons, Catherine, Daniel, Virginie, Westeel, Anne, Madroszyk, Hervé, Léna, Patrick, Merle, Julien, Mazières, Gérard, Zalcman, Roger, Lacave, Martine, Antoine, Franck, Morin, Pascale, Missy, Fabrice, Barlesi, Pascal, Auquier, and Jacques, Cadranel
- Subjects
Adult ,Aged, 80 and over ,Male ,Lung Neoplasms ,Cost-Benefit Analysis ,DNA Mutational Analysis ,Decision Making ,Middle Aged ,ErbB Receptors ,Proto-Oncogene Proteins p21(ras) ,Carcinoma, Non-Small-Cell Lung ,Mutation ,Pulmonary Medicine ,Humans ,Anaplastic Lymphoma Kinase ,Female ,France ,Genetic Testing ,Longitudinal Studies ,Biomarkers ,Aged - Published
- 2017